CRISPR-Cas13 Inhibitors Block RNA Editing in Bacteria and Mammalian Cells.

Journal: Molecular Cell

Published: 2020-04-18

DOI: 10.1016/j.molcel.2020.03.033

Affiliations: 12

Authors: 15

Go to article
Institutions Share
Department of Biomedical Sciences, UND, United States of America (USA) 0.39
West China School of Medicine/West China Hospital of Sichuan University (WCSM/WCH), SCU, China 0.17
West China School of Basic Medical Sciences and Forensic Medicine (WCSBMSFM), SCU, China 0.10
Jiangsu Provincial Key Laboratory for Biotechnology on Medicinal Plants, JSNU, China 0.07
Affiliated Hospital of Southwest Medical University, China 0.07
Trauma Center, Daping Hospital, China 0.06
State Key Laboratory of Trauma, Burns and Combined Injury, TMMU, China 0.06
Ruijin Hospital, SJTU, China 0.03
CAS Key Laboratory of Pathogenic Microbiology and Immunology, IM CAS, China 0.02
Savaid Medical School, UCAS, China 0.02
National Institute for Viral Disease Control and Prevention (IVDC), China CDC, China 0.02
Research Network of Immunity and Health (RNIH), BIOLS CAS, China 0.02

Return

Except where otherwise noted © 2020 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER